German government takes a stake in vaccine developer CureVac

By |junij 15th, 2020|coronavirus, coronavirus vaccine, COVID-19, CureVac, Dietmar Hopp, News, Peter Altmaier|

In the global race for a coronavirus vaccine, the German government is investing €300 million and acquiring a stake in the biotech company CureVac, regarded as one of the leaders in the development of a vaccine in Germany. EURACTIV Germany reports.